Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation

Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA.
Blood (Impact Factor: 10.43). 03/2010; 115(23):4742-9. DOI: 10.1182/blood-2009-10-249540
Source: PubMed

ABSTRACT Dendritic cells (DCs) are key regulators of innate and acquired immunity. The maturation of DCs is directed by signal transduction events downstream of toll-like receptors (TLRs) and other pattern recognition receptors. Here, we demonstrate that, in mouse DCs, TLR agonists stimulate a profound metabolic transition to aerobic glycolysis, similar to the Warburg metabolism displayed by cancer cells. This metabolic switch depends on the phosphatidyl inositol 3'-kinase/Akt pathway, is antagonized by the adenosine monophosphate (AMP)-activated protein kinase (AMPK), and is required for DC maturation. The metabolic switch induced by DC activation is antagonized by the antiinflammatory cytokine interleukin-10. Our data pinpoint TLR-mediated metabolic conversion as essential for DC maturation and function and reveal it as a potential target for intervention in the control of excessive inflammation and inappropriately regulated immune responses.

Download full-text


Available from: Jie Sun, Jul 22, 2015
1 Follower
  • Source
    • "It has been demonstrated that the shift toward aerobic glycolysis induced in DCs by TLR stimulation is driven by the PI3K/Akt pathway. In turn, this process is antagonized by AMPK [17] (Fig. 1). The upregulated aerobic glycolysis insures the energy need of DC activation, and supports the de novo synthesis of fatty acids for the expansion of the endoplasmic reticulum and Golgi for the production and secretion of the effector proteins such as cytokines [21]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A growing body of recent studies bring into light an important crosstalk between immune response and metabolism not only at the level of the organism as a whole, but also at the level of the individual cells. Cellular bioenergetics functions not only as a power plant to fuel up the cells, but the intermediate metabolites are shown to play an important role to modulate cellular responses. It is especially the pathways through which a cell metabolizes glucose that have been recently shown to influence both innate and adaptive immune responses, with oxidative phosphorylation used by resting or tolerant cells, while aerobic glycolysis (also termed ‘Warburg effect’) fueling activated cells. In this review we will address how the center metabolism shifts upon activation in the innate immune cells and how the intermediates metabolites modulate the function of immune cells.
    Cytokine & Growth Factor Reviews 12/2014; 25(6). DOI:10.1016/j.cytogfr.2014.06.008 · 6.54 Impact Factor
  • Source
    • "can induce HIF-1-dependent metabolic reprogramming toward glycolysis. Toll-like receptor agonists stimulate a metabolic transition to aerobic glycolysis in dendritic cells (DCs) and macrophages, a conversion essential for their maturation and function (Krawczyk et al., 2010; Tannahill et al., 2013). In DCs, nitric oxide is a key player in this switch by acting on components of the mitochondrial ETC to inhibit oxidative phosphorylation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Evidence accumulating over the past decade has linked alterations in bioenergetic metabolism to the pathogenesis of several diseases, including inflammatory conditions and cancer. However, the mutual relationship between the effector functions and the metabolism of immune cells has begun to emerge only recently. Similar to malignant cells, both innate and adaptive immune cells undergo a metabolic reprogramming that is required for effector functions, de facto underlying the elicitation of a robust immune response. These changes allow immune cells not only to rapidly respond to pathogens or (pre)malignant cells but also to adapt to changing microenvironmental conditions. Targeting the metabolic alterations of malignant cells has been the subject of an intense wave of investigation, resulting in the identification of promising therapeutic strategies. Since the inflammatory milieu and the tumor microenvironment are similar, the metabolism of immune cells and its regulation has recently come under renewed interest as a target for immunotherapy. Here, we describe different tools and techniques to study the bioenergetic metabolism of cultured cells, using immune cells as a model. Our methodological approach relies on an extracellular flux analyzer, an instrument that enables the real-time measurement of the two central pathways used by living cells to generate adenosine triphosphate: glycolysis and oxidative phosphorylation. This instrument and similar technological innovations have transformed the study of cellular metabolism, unveiling its profound impact on various immunologic and oncological disorders.
    Methods in Enzymology 01/2014; 542:125-49. DOI:10.1016/B978-0-12-416618-9.00007-8 · 2.19 Impact Factor
  • Source
    • "Naïve dendritic cells when activated using TLR ligands or pro-inflamtory cytokines, shift their metabolism from oxidative phosphorylation to aerobic glycolysis (i.e., the Warburg effect). Krawczyk et al. described this phenomenon in DCs and also demonstrated how TLR stimulation is essential for dendritic cell maturation [47]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dendritic cells (DCs) link the sensing of the environment by the innate immune system to the initiation of adaptive immune responses. Accordingly, DCs are considered to be a major target in the development of immunomodulating compounds. In this study, the effect of niclosamide, a Food and Drug Administration-approved antihelminthic drug, on the activation of lipopolysaccharide (LPS)-stimulated murine bone marrow-derived DCs was examined. Our experimental results show that niclosamide reduced the pro-inflammatory cytokine and chemokine expression of LPS-activated DCs. In addition, niclosamide also affected the expression of MHC and costimulatory molecules and influenced the ability of the cells to take up antigens. Therefore, in mixed cell cultures composed of syngeneic OVA-specific T cells and DCs, niclosamide-treated DCs showed a decreased ability to stimulate T cell proliferation and IFN-γ production. Furthermore, intravenous injection of niclosamide also attenuated contact hypersensitivity (CHS) in mice during sensitization with 2,4-dinitro-1-fluorobenzene. Blocking the LPS-induced activation of MAPK-ERK, JNK and NF-κB may contribute to the inhibitory effect of niclosamide on DC activation. Collectively, our findings suggest that niclosamide can manipulate the function of DCs. These results provide new insight into the immunopharmacological role of niclosamide and suggest that it may be useful for the treatment of chronic inflammatory disorders or DC-mediated autoimmune diseases.
    Cellular Immunology 12/2013; 288(1-2):15-23. DOI:10.1016/j.cellimm.2013.12.006 · 1.87 Impact Factor
Show more